Top 10 Biotech VC (Venture Capital) Funds in Estonia in December 2024
A list of 10 VC (Venture Capital) funds that invest in Biotech startups based in Estonia. We rank investors based on the number of investments they made in Biotech companies from Estonia. We update this investor list every month.Top 10 Biotech VC (Venture Capital) Funds in Estonia in December 2024
Investor | Biotech Estonia investments |
---|---|
Enterprise Estonia | 3 |
Nordic Foodtech VC | 2 |
Grid.vc | 1 |
European Investment Bank | 1 |
Domain Associates | 1 |
SOSV | 1 |
Johnson & Johnson Development Corporation | 1 |
Crosslight Partners | 1 |
Voima Ventures | 1 |
UniTartu Ventures | 1 |
Enterprise Estonia (EAS), established in 2000, promotes business and regional development in Estonia. Enterprise Estonia is one of the largest institutions within the national support system for entrepreneurship, providing financial assistance, advisory, cooperation opportunities and training for entrepreneurs, research establishments, public andthird sector.
Show more
Investment focus
- Mobile Apps, CleanTech, Manufacturing
- Grant, Seed, Pre-Seed
- Estonia
Portfolio highlights
- ÄIO — Innovative food technologies to replace palm oil, coconut oil and animal fats with sustainable and healthier alternatives.
- MYCEEN — We grow carbon-negative materials combining mushroom mycelium and industrial byproducts.
- Vok Bikes — E-cargo bicycles perfect for last-mile deliveries and business use cases in the city. Vok Bikes develops and produces electric cargo bikes in Europe.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more
Investment focus
- Biotechnology, Life Science, Water
- Seed, Series A, Funding Round
- Finland, Sweden, Denmark
Portfolio highlights
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Happy Plant Protein — Changing the way plant proteins are made
Grid.vc is the first investor in superb teams disrupting the energy business.
Show more
Investment focus
- Energy, Renewable Energy, SaaS
- Seed, Pre-Seed, Funding Round
- Finland, Estonia
Portfolio highlights
- Bioreactor — Bioreactor is a revolutionary technology that converts bio waste into clean energy through biomass gasification. It's a sustainable, efficient and cost-effective solution that addresses energy poverty, energy security and climate change. With the use of the latest technology in computational fluid dynamics, cloud-optimized digital twin anddeep learning algorithms, the Bioreactor can optimize its performance in real-time over a wide range of fuels and operating conditions. The Bioreactor is a game changer in the energy industry, it can reduce greenhouse gas emissions, drastically lower energy costs, and help to alleviate energy poverty on a national scale.
- Safegrid — Smarter sensors for a smarter grid
- Vensum Power — Revolutionizing power conversion. More power in same package, less energy waste and low maintenance.
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
- Biotechnology, Health Care, Energy
- Debt Financing, Post-IPO Debt, Funding Round
- France, Germany, The Netherlands
Portfolio highlights
- BURN — The future of clean cooking
- GEWOBA — GEWOBA is a real estate company that manages and provides a diverse portfolio of rental real estate apartments and properties.
- Acea — Acea operates in six business segments. The water segment collects, purchases, transports and distributes drinking water, and manages the sewerage system and the purification of wastewaters. The company serves 9 million residents served in Lazio, Tuscany, Umbria, Molise and Campania; The energy segment manages the transmission and distributesroughly 9 TWh of electricity, public lighting; commercial and trading segment activities include energy management, sale of electricity and gas, energy efficiency for domestic customers. The company is targeting growth in electricity generation from renewable (photovoltaic) sources and in electric mobility, with a view to effectively contributing more and more to the energy transition and decarbonisation. The environment segment provides laboratory, research and related consultancy services on the environment and control functions within the water cycle; engineering services and overseas operations providing water services in Latin America.
INVESTMENT ADVISORS TO THE FIRST VC FUND DEDICATED TO BIOTECH
INVESTMENT MANAGER OF 9 SUBSEQUENT BIOTECH VC FUNDS
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series C, Series A
- United States, Canada, Estonia
Portfolio highlights
- Epic Sciences — Epic Sciences develops clinical solutions that accelerate drug development and guided therapy across cancer drug indications. Epic's new AR-V7 CTC liquid biopsy test is the first clinically proven predictive test for metastatic castration-resistant prostate cancer.
- Antios Therapeutics — This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I'm a bike messenger
- Fractyl Health — Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series C, Series B, Funding Round
- United States, United Kingdom, Canada
Portfolio highlights
- CVRx — CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left andright carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota.
- Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
- Osteal Therapeutics — Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
Crosslight Partners is a growth equity firm. The firm invests in the environment, healthcare, impact, and technology sectors across Europe.
Show more
Investment focus
- Biotechnology, B2B, Medical
- Seed, Funding Round
- Sweden, Estonia
Portfolio highlights
- Gelatex Technologies — Gelatex is a Techstars-backed materials technology company that invented the fastest technology for producing bio-based nanofibers on a large scale. It is a platform technology that enables faster and up to 100 cheaper nanofiber production for applications like 3D scaffolds for tissue engineering, cultured meat, bio-based filters, eco-friendlyleather-like textile, energy storage, wound care, and many more. The technology is patent-pending and the machinery fully functional. The company was founded in 2016 and until COVID-19 pandemic developed eco-friendly leather-like textile from gelatin nanofibers, using this nanofiber production technology as part of the process. COVID-19 was a trigger to understand the wider potential of the technology which then led to pivot.The company is based in Estonia and holding incorporated in UK (2019).
- Sigrid Therapeutics — Safe Solution For Normalizing Blood Sugar Levels
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Seed, Pre-Seed, Funding Round
- Finland, Sweden, Norway
Portfolio highlights
- NADMED — The standard of NAD measuring
- Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
- Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
UniTartu Ventures team up with early-stage deep tech investors to support the University of Tartu's connected researchers, startups, and spin-off’s growth.
Show more
Investment focus
- Biotechnology, Nanotechnology
- Pre-Seed
- Estonia
Portfolio highlights
- UP Catalyst — UP Catalyst produces sustainable carbon nanomaterials and graphite for the green energy storage industry.
- Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
Investors by industry
Biotech
Proptech
Gaming
FinTech
Health Care
Community
Google
Marketplace
Climate
Consumer
Artificial intelligence
Impact
Energy
Hardware
EdTech
Sustainability
Venture Capital
Clean Energy
B2B
Real Estate
Publishing
Payments
Big Data
Retail
Organic Food
Web3
Education
Finance
Food and Beverage
Video Games
Infrastructure
Financial Services
Photography
Beauty
Medical
Wellness
Social Media
Social Network
Android
Construction
Art
Local
Legal
Digital Media
Manufacturing
eSports
Sports
Music
Mobile
Internet
Enterprise Software
Franchise
Email
Travel
Mobile Advertising
Biotechnology
Recruiting
Hospitality
Fitness
Platforms
Cannabis
Medical Device
Social
Automotive
Crowdfunding
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Social Impact
Restaurants
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Canada
New Zealand
Ireland
United States
Qatar
Saudi Arabia
Spain
Sri Lanka
China
Middle East
Africa
Indonesia
Europe
Armenia
Singapore
Oceania
Brazil
Japan
South Africa
Vietnam
LATAM
Asia
Denmark
Costa Rica
Bermuda
Egypt
Croatia
Gibraltar
Algeria
Estonia
Ecuador
Greece
Chile
Bulgaria
Ethiopia
Hong Kong
Faroe Islands
France
Ghana
Czech Republic
Hungary
Georgia
Belgium
Finland
Bahrain
Belarus
Belize
Barbados
Lebanon
Mali
Liberia
Malta
Liechtenstein
Malaysia
Italy
Panama
Myanmar
Mauritius
Nicaragua
Philippines
Puerto Rico
Tunisia
Uganda
Sierra Leone
Senegal
Lithuania
San Marino
Uzbekistan
Seychelles
Togo
El Salvador
Rwanda
Russian Federation
Israel
Tanzania
Ukraine
Zimbabwe
Uruguay
Serbia
Taiwan
Venezuela
Tajikistan
Sweden
Turkey
Poland
Thailand
Zambia
Portugal
Slovenia
Dominican Republic
Azerbaijan
Jersey
Iraq
Iceland
Bahamas
Namibia
Nigeria
United Arab Emirates
Norway
Jamaica
Honduras
Morocco
Bolivia
Isle of Man
Mexico
Luxembourg
Peru
Kuwait
Bangladesh
Albania
Pakistan
Argentina
Grenada
Jordan
Romania
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Guatemala
Colombia
Marshall Islands
VC (Venture Capital) Funds in Estonia by industry
Travel
Financial Services
Big Data
Cryptocurrency
Finance
Food and Beverage
Payments
Medical
Medical Device
Transportation
Internet
Manufacturing
Mobile
Blockchain
Construction
Software
Sports
Automotive
FinTech
Recruiting
Enterprise
Consumer
Health Care
Biotech
Sustainability
EdTech
Climate
Energy
SaaS
Proptech
Impact
Crowdfunding
Marketplace
Artificial intelligence
Community
Hardware
Gaming
Mobile Apps
Retail
Fashion
Infrastructure
B2B
Web3
Renewable Energy
Education
Real Estate
CleanTech
Biotechnology
Media (entertainment)
Agriculture (agtech)
Social Impact
Hospitality